Myths About Surgical Myectomy: Rumors of Its Death Have Been Greatly Exaggerated

American Journal of Cardiology

Volumn 101, Issue 6, 2008, Pages 887-889

  Maron, Barry J ^a   Ommen, Steve R ^b   Nishimura, Rick A ^b   Dearani, Joseph A ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL SEPTAL ABLATION; ARTICLE; CLINICAL PRACTICE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MINIMALLY INVASIVE SURGERY; MUSCLE RESECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 40149087315     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.10.055     Document Type: Note

References (36)

1. B.J. Maron Controversies in cardiovascular medicine Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 116 2007 196 206
2. M.A. Fifer Controversies in cardiovascular medicine Most fully informed patients choose septal ablation over septal myectomy Circulation 116 2007 207 216
3. B.J. Maron W.J. McKenna G.K. Danielson L.J. Kappenberger H.J. Kuhn C.E. Seidman P.M. Shah W.H. Spencer P. Spirito F.J. ten Cate E.D. Wigle American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy J Am Coll Cardiol 42 2003 1687 1713
4. S.R. Ommen B.J. Maron I. Olivotto M.S. Maron F. Cecchi S. Betocchi B.J. Gersh M.J. Ackerman R.B. McCully J.A. Dearani Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 470 476
5. M.S. Maron I. Olivotto S. Betocchi S.A. Casey J.R. Lesser M.A. Losi F. Cecchi B.J. Maron Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
6. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
7. B.J. Maron J.A. Dearani S.R. Ommen M.S. Maron H.V. Schaff B.J. Gersh R.A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2044 2053
8. O.M. Hess Risk stratification in hypertrophic cardiomyopathy: fact or fiction? J Am Coll Cardiol 42 2003 880 881
9. U. Sigwart Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 346 1995 211 214
10. C.J. Knight Alcohol septal ablation for obstructive hypertrophic cardiomyopathy Heart 92 2006 1339 1344
11. O.M. Hess U. Sigwart New treatment strategies for hypertrophic obstructive cardiomyopathy Alcohol ablation of the septum: the new gold standard J Am Coll Cardiol 44 2004 2054 2055
12. E.J. Smith A.K. Jain C.J. Knight Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: how and when? Br J Cardiol 13 2006 58 61
13. R. Roberts U. Sigwart Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy Circulation 112 2005 293 296
14. C. Oakley Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy Br Heart J 74 1995 479 480
15. I. Olivotto S.R. Ommen M.S. Maron F. Cecchi B.J. Maron Surgical myectomy versus percutaneous alcohol septal ablation for obstructive hypertrophic cardiomyopathy: will there ever be a randomized trial? J Am Coll Cardiol 50 2007 831 834
16. C.D. Kimmelstiel B.J. Maron Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy Circulation 109 2004 452 456
17. M. Alam H. Dokaninish N. Lakkis Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies J Interv Cardiol 19 2006 319 327
18. R.G. Hauser B.J. Maron Lessons from the failure and recall of an implantable cardioverter defibrillator Circulation 112 2005 2040 2042
19. B.J. Maron Surgery for hypertrophic obstructive cardiomyopathy: alive and quite well Circulation 111 2005 2016 2018
20. M.H. Yacoub Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy The pendulum swings Circulation 112 2005 450 452
21. N.G. Smedira H.M. Lever M. Miluk G. Krishnaswamy G. Laing M. Thamilarasan B.W. Lytle E.H. Blackstone E.J. Topol Septal myectomy: 324 consecutive procedures without a mortality [abstract] J Am Coll Cardiol 47 suppl 2006 275A
22. A. Woo W.G. Williams R. Choi E.D. Wigle E. Rozenblyum K. Fedwick S. Siu A. Ralph-Edwards H. Rakowski Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy Circulation 111 2005 2033 2041
23. M.J. Kofflard L.A. van Herwerden D.J. Waldstein P. Ruygrok E. Boersma A. Tammas F.J. ten Cate Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 28 1996 197 202
24. M.S. Maron I. Olivotto A.G. Zenovich M.S. Link N.G. Pandian J.T. Kuvin S. Nistri F. Cecchi J.E. Udelson B.J. Maron Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239
25. B.J. Maron Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy Lancet 35 2000 425 426
26. P. Spirito B.J. Maron Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 33 1999 1071 1075
27. R.B. McCulley R.A. Nishimura A.J. Tajik H.V. Schaff G.K. Danielson Extent clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy Circulation 94 1996 467 471
28. K. Minakata J.A. Dearani H.V. Schaff P.W. O’Leary S.R. Ommen G.K. Danielson Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy Ann Thorac Surg 80 2005 851 856
29. A. Ralph-Edwards A. Woo B.W. McCrindle J.L. Shapero L. Schwartz H. Rakowski E.D. Wigle W.G. Williams Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score J Thorac Cardiovasc Surg 129 2005 351 358
30. B.J. Maron W.H. Merrill P.A. Freier K.M. Kent S.E. Epstein A.G. Morrow Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis Circulation 57 1978 1205 1213
31. K.M. Harris P. Spirito M.S. Maron A.G. Zenovich F. Formisano J.R. Lesser S. Mackey-Bojack W.J. Manning J.E. Udelson B.J. Maron Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
32. U.S. Valeti R.A. Nishimura D.R. Holmes P.A. Araoz J.F. Glockner J.F. Breen S.R. Ommen B.J. Gersh A.J. Tajik C.S. Rihal Comparison of surgical septal myectomy and alcohol septal ablation by cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 49 2007 350 357
33. C.J. McLeod S.R. Ommen M.J. Ackerman P.L. Weivoda W.-K. Shen J.A. Dearani H.V. Schaff A.J. Tajik B.J. Gersh Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur Heart J 28 2007 2583 2588
34. B.J. Maron P. Spirito W.-K. Shen T.S. Haas F. Formisano M.S. Link A.E. Epstein A.K. Almquist J.P. Daubert T. Lawrenz Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
35. D.R. Talreja R.A. Nishimura W.D. Edwards U.S. Valeti S.R. Ommen A.J. Tajik J.A. Dearani H.V. Schaff D.R. Holmes Jr Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue J Am Coll Cardiol 44 2004 2329 2332
36. J.X. Qin T. Shiota H.M. Lever C.R. Asher Z.B. Popovic N.L. Greenberg D.A. Agler J.K. Drinko N.G. Smedira E.M. Tuzcu Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions Am J Cardiol 93 2004 171 175